Anecdotal and clinical evidence suggests that mechanical unloading may restore cardiac function by inducing changes in the biological properties of the failing heart. This challenges the notion that the progression of end-stage heart failure is an irreversible process ending in either death of the patient or transplantation. Although it is still not clear how mechanical unloading of the failing heart improves cardiac function, the process likely involves adaptive responses of cardiac myocytes on the cellular, extracellular, and subcellular levels.

1.
Dasse K, Frazier O, Lesniak J, Myers T, Burnett C, Poirier V: Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J 1992;38:M622–M626.
2.
Razeghi P, Mukhopadhyay M, Myers TJ, Williams JN, Moravec CS, Frazier OH, Taegtmeyer H: Myocardial TNFα expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg 2001;72:2044–2050.
3.
Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM: Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 1996;62:675–682.
4.
Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, Kayne HL, Poirier VL, Dasse KA: Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327–338.
5.
Frazier O, Radovancevic B, Abou-Awdi N, et al: Ventricular remodeling after prolonged ventricular unloading ‘heart rest’: Experience with the HeartMate left ventricular assist device. J Heart Lung Transplant 1994;13:S51.
6.
Muller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R: Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 1997;96:542–549.
7.
Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Cordisco ME, Rose E, Oz M: Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 1998;98:2383–2389.
8.
Frazier O, Myers T: Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 1999;68:734–741.
9.
Yacoub MH: A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 2001;22:534–540.
10.
Frazier OH: First use of an untethered, vented electric left ventricular assist device for long-term support. Circulation 1994;89:2908–2914.
11.
Goodwin G, Taylor C, Taegtmeyer H: Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998;273:29530–29539.
12.
Taegtmeyer H: Genetics of energetics: Transcriptional responses in cardiac metabolism. Ann Biomed Eng 2000;28:871–876.
13.
Burch G, Walsh J, Ferrans V, Hibbs R: Prolonged bed rest in the treatment of the dilated heart. Circulation 1965;32:852–856.
14.
Scheinin S, Capek P, Radovancevic B, Duncan J, McAllister HJ, Frazier O: The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy. ASAIO J 1992;38:M271–M274.
15.
McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, Savage RM, Thomas JD: Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg 1995;59:609–613.
16.
Altemose G, Gritsus V, Jeevanandam V, Goldman B, Margulies K: Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant 1997;16:765–773.
17.
Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB: Regression of cellular hypertrophy after left ventricular assist device support. Circulation 1998;98:656–662.
18.
Bruckner BA, Stetson SJ, Perez-Verdia A, Youker KA, Radovancevic B, Connelly JH, Koerner MM, Entman ME, Frazier OH, Noon GP, Torre-Amione G: Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001;20:457–464.
19.
de Jonge N, van Wichen DF, Schipper ME, Lahpor JR, Gmelig-Meyling FH, Robles de Medina EO, de Weger RA: Left ventricular assist device in end-stage heart failure: Persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol 2002;39:963–969.
20.
Aquila-Pastir LA, McCarthy PM, Smedira NG, Moravec CS: Mechanical unloading decreases the expression of beta-tubulin in the failing human heart. J Heart Lung Transplant 2001;20:211.
21.
Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre-Amione G, Bowles NE, Towbin JA: Molecular remodeling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 2002;359:936–941.
22.
Rivello H, Meckert P, Vigliano C, Favaloro R, Laguens R: Cardiac myocyte nuclear size and ploidy status decrease after mechanical support. Cardiovasc Pathol 2001;10:53–57.
23.
Bruckner BA, Stetson SJ, Farmer JA, Radovancevic B, Frazier OH, Noon GP, Entman ML, Torre-Amione G, Youker KA: The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg 2000;180:498–501.
24.
Li YY, Feng Y, McTiernan CF, Pei W, Moravec CS, Wang P, Rosenblum W, Kormos RL, Feldman AM: Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 2001;104:1147–1152.
25.
Li Y, McTiernan C, Feldman A: Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000;46:214–224.
26.
Mann DL, Taegtmeyer H: Dynamic regulation of the extracellular matrix after mechanical unloading of the failing human heart: Recovering the link in left ventricular remodeling. Circulation 2001;104:1089–1091.
27.
Razeghi P, Bruckner B, Thompson L, Noon G, Youker K, Taegtmeyer H: Altered gene expression of matrix-metalloproteinases and tissue inhibitors of metalloproteinases in patients supported by left ventricular assist devices. J Am Coll Cardiol 2002;39:198A.
28.
Dipla K, Mattiello J, Jeevanandam V, Houser S, Margulies K: Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 1998;97:2316–2322.
29.
Ogletree-Hughes ML, Stull LB, Sweet WE, Smedira NG, McCarthy PM, Moravec CS: Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001;104:881–886.
30.
Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D: Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 2000;102:2713–2719.
31.
Barbone A, Holmes JW, Heerdt PM, The’ AH, Naka Y, Joshi N, Daines M, Marks AR, Oz MC, Burkhoff D: Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: A primary role of mechanical unloading underlying reverse remodeling. Circulation 2001;104:670–675.
32.
Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR: PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts. Cell 2000;101:365–376.
33.
Harding J, Piacentino V 3rd, Gaughan J, Houser S, Margulies K: Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation 2001;104:1241–1247.
34.
Conway M, Allis J, Duwerkerk R, Niioua T, Rajagopalan B, Radda G: Low phosphocreatine/ATP ratio detected in vivo in the failing hypertrophied human myocardium using 31P magnetic resonance spectroscopy. Lancet 1991;338:973–976.
35.
Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies PJ, Taegtmeyer H: Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998;4:1269–1275.
36.
Doenst T, Goodwin G, Cedars A, Wang M, Stepkowski S, Taegtmeyer H: Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Metabolism 2001;50:1083–1090.
37.
Razeghi P, Young ME, Ying J, Depre C, Uray IP, Kolesar J, Shipley GL, Moravec CS, Davies PJ, Frazier OH, Taegtmeyer H: Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 2002;97:203–209.
38.
Lee S, Doliba N, Osbakken M, Oz M, Mancini D: Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. J Thorac Cardiovasc Surg 1998;116:344–349.
39.
Mital S, Loke K, Addonizio L, Oz M, Hintze T: Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts. J Am Coll Cardiol 2000;36:1897–1902.
40.
Razeghi P, Young M, Alcorn J, Moravec C, Frazier O, Taegtmeyer H: Metabolic gene expression in fetal and failing human heart. Circulation 2001;104:2923–2931.
41.
Eiken HG, Oie E, Damas JK, Yndestad A, Bjerkeli V, Aass H, Simonsen S, Geiran OR, Tonnessen T, Christensen G, Froland SS, Gullestad L, Attramadal H, Aukrust P: Myocardial gene expression of leukaemia inhibitory factor, interleukin-6 and glycoprotein 130 in end-stage human heart failure. Eur J Clin Invest 2001;31:389–397.
42.
Dibbs Z, Kurrelmeyer K, Kalra D, et al: Cytokines in heart failure: Pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians 1999;111:423–428.
43.
Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL: Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001;103:1044–1047.
44.
Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP: Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation 1999;100:1189–1193.
45.
Grabellus F, Levkau B, Sokoll A, Welp H, Schmid C, Deng MC, Takeda A, Breithardt G, Baba HA: Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 2002;53:124–130.
46.
Tedgui A, Mallat Z: Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001;88:877–887.
47.
Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S: Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci USA 1999;96:8144–8149.
48.
Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, Koerner MM, El-Banayosy A, Koerfer R, Holtz J, Zerkowski HR: Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation 1999;100:II216–II223.
49.
Uray IP, Connelly JH, Frazier OH, Taegtmeyer H, Davies PJ: Altered expression of tyrosine kinase receptors Her2/neu and GP130 following left ventricular assist device (LVAD) placement in patients with heart failure. J Heart Lung Transplant 2001;20:210.
50.
Flesch M, Margulies K, Mochmann H, Engel D, Sivasubramanian N, Mann D: Differential regulation of mitogen-activated protein kinases in the failing human heart in response to mechanical unloading. Circulation 2001;104:2273–2276.
51.
Baba HA, Grabellus F, August C, Plenz G, Takeda A, Tjan TD, Schmid C, Deng MC: Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant 2000;19:668–674.
52.
Francis G, Anwar F, Bank A, Kubo S, Jessurun J: Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: Observations made after implantation of left ventricular assist device. J Card Fail 1999;5:308–315.
53.
Depre C, Taegtmeyer H: Metabolic aspects of programmed cell survival and cell death in the heart. Cardiovasc Res 2000;45:538–548.
54.
Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750–1757.
55.
Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–705.
56.
Bartling B, Mitling H, Schumann H, et al: Improved myocardial expression of anti-apoptotic genes under support by ventricular assist devices (VAD) in terminal heart failure (abstract). Circulation 1998;98:I-200.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.